Skip to main content
. Author manuscript; available in PMC: 2024 May 13.
Published in final edited form as: J Hepatol. 2021 Jun 21;75(5):1026–1033. doi: 10.1016/j.jhep.2021.06.019

Fig. 1. Impact of steroid use in terms of severity at 30, 90 and 180 days.

Fig. 1.

(A), Changes in MELD score between admission and 30, 90 and 180 days according to steroid use. (B), Change in serum bilirubin between admission and by day 7 according to steroid use. The groups were compared with the Mann-Whitney U test, and a p value <0.05 was considered significant. MELD, model for end-stage liver disease; n.s., not significant.